T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
T‐lymphokine‐activated killer (T‐LAK) cell‐originated protein kinase (TOPK) is an emerging target with critical roles in various cancers; however, its expression and function in osteosarcoma remain unexplored. We evaluated TOPK expression using RNA sequencing and gene expression data from public dat...
Guardado en:
Autores principales: | Pichaya Thanindratarn, Ran Wei, Dylan C. Dean, Arun Singh, Noah Federman, Scott D. Nelson, Francis J. Hornicek, Zhenfeng Duan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dad7f96840d24a35ade73793916c2808 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma
por: Jian Zhang, et al.
Publicado: (2021) -
Tratamiento adyuvante (Conpadri I) en osteosarcoma infantil (Valdivia 1980-1990)
por: Zolezzi R,Paola, et al.
Publicado: (1992) -
Tumor Phyllodes con transformación a osteosarcoma
por: Nieto-Coronel,Tereza, et al.
Publicado: (2017) -
Primary breast osteosarcoma: A case report and review of the literature
por: Ramesh Omranipour, et al.
Publicado: (2021) -
Low‐grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw
por: Aya Sasaki, et al.
Publicado: (2021)